Skip to content

Therapeutic effect of continuous theta burst transcranial magnetic stimulation on insomnia after novel coronavirus infection

Therapeutic effect of continuous theta burst transcranial magnetic stimulation on insomnia after novel coronavirus infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085860
Enrollment
Unknown
Registered
2024-06-19
Start date
2023-02-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia after novel coronavirus infection

Interventions

Observation group:none

Sponsors

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?New onset of insomnia within 2 weeks after the new crown infection ?No insomnia symptoms before the new crown infection ?Age 18~80 years old ?Meet the diagnostic criteria for sleep disorders in the International Classification of Sleep Disorders, Third Edition (ICSD-30) : dissatisfaction with the quantity or quality of sleep, difficulty initiating or maintaining sleep, must have at least one sleep complaint such as difficulty falling asleep, and must be present at least 3 nights per week. ? NO pacemakers or other metal-implanted devices ? informed and consenting to participate in the study and able to cooperate in completing the follow-up

Exclusion criteria

Exclusion criteria: ?Do not meet the clinical diagnostic criteria for insomnia ?History of insomnia, depression, and anxiety before the onset ?Severe cognitive and communication disorders, etc., cannot cooperate ?Patients with combined heart, liver, kidney and other important organs and serious organic diseases and serious primary diseases such as hematopoietic system and endocrine system ? Patients with neurological diseases contraindicated for TMS (such as cerebral hemorrhage, cranial defect, epilepsy, tumor, traumatic brain injury, etc.) and family history ? Patients with contraindications to TMS stimulation: cochlear implants, pacemakers, intracerebral neurostimulators, intracranial metals ? Pregnancy status ? not tolerate TMS

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;

Secondary

MeasureTime frame
Self-rating anxiety scale;Insomnia Severity Index;

Countries

China

Contacts

Public ContactSong Di

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

songdi_journey@163.com+86 173 2126 1005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026